Shattuck Labs, Inc.
COMBINATION THERAPIES COMPRISING PD-1-BASED CHIMERIC PROTEINS
Last updated:
Abstract:
The present invention relates to, inter alia, combinations of compositions which include chimeric proteins that find use in methods for treating disease, such as immunotherapies for cancer and autoimmunity.
Status:
Application
Type:
Utility
Filling date:
29 Aug 2019
Issue date:
7 Oct 2021